Clinical outcomes after cardiac transplantation in muscular dystrophy patients

Patients with muscular dystrophy are at risk of developing a dilated cardiomyopathy and can progress to advanced heart failure. At present, it is not known whether such patients can safely undergo cardiac transplantation. This was a retrospective review of the Cardiac Transplant Research Database, a...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of heart and lung transplantation Vol. 29; no. 4; pp. 432 - 438
Main Authors Wu, Roland S., Gupta, Sachin, Brown, Robert N., Yancy, Clyde W., Wald, Joyce W., Kaiser, Patricia, Kirklin, Nicole M., Patel, Parag C., Markham, David W., Drazner, Mark H., Garry, Daniel J., Mammen, Pradeep P.A.
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.04.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Patients with muscular dystrophy are at risk of developing a dilated cardiomyopathy and can progress to advanced heart failure. At present, it is not known whether such patients can safely undergo cardiac transplantation. This was a retrospective review of the Cardiac Transplant Research Database, a multi-institutional registry of 29 transplant centers in the United States, from the years 1990 to 2005. The post-cardiac transplant outcomes of 29 patients with muscular dystrophy were compared with 275 non-muscular dystrophy patients with non-ischemic cardiomyopathy, matched for age, body mass index, gender, and race. Becker's muscular dystrophy was present in 52% of the patients. Survival in the muscular dystrophy patients was similar to the controls at 1 year (89% vs 91%; p = 0.5) and at 5 years (83% vs 78%; p = 0.5). The differences in rates of cumulative infection, rejection, or allograft vasculopathy between the 2 groups were not significant (p > 0.5 for all comparisons). Recognizing the limitations of the present investigation (ie, selection bias and data lacking in the functional capacity of the muscular dystrophy patients), the current study suggests that the clinical outcomes after cardiac transplantation in selected patients with muscular dystrophy are similar to those seen in age-matched patients with non-ischemic cardiomyopathy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1053-2498
1557-3117
1557-3117
DOI:10.1016/j.healun.2009.08.030